Highlights Lincoln Pharmaceuticals Limited

Equities

LINCOLN

INE405C01035

Market Closed - Bombay S.E. Other stock markets 06:00:54 2024-06-28 EDT			5-day change	1st Jan Change
612.2 ^INR	+0.30%		-0.58%	+0.50%

05-20	Lincoln Pharmaceuticals Limited Announces Director Appointments	CI
05-16	Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024	05-16	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Full Year Ended March 31, 2024	05-16	CI
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2024	05-16	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023	02-08	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023	11-02	CI
Lincoln Pharmaceuticals Limited Declares Dividend for the Financial Year 2022-23	23-09-30	CI
Lincoln Pharmaceuticals Limited Proposes Dividend for the Financial Year 2022-2023	23-09-06	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2023	23-08-10	CI
Lincoln Pharmaceuticals Limited Recommends A Dividend for the Year Ended March 31, 2023	23-05-25	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2023	23-05-25	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022	23-02-09	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2022	22-11-10	CI
Lincoln Pharmaceuticals Limited Approves to Declare Dividend for the Financial Year 2021-22	22-09-30	CI
Lincoln Pharmaceuticals Limited Proposes to Declare Dividend for the Financial Year 2021-2022	22-09-06	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the First Quarter Ended June 30, 2022	22-08-09	CI
Lincoln Pharmaceuticals Limited Recommends Dividend for the Year Ended March 31, 2022	22-05-19	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021	22-02-10	CI
Lincoln Pharmaceuticals Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2021	21-11-11	CI
Lincoln Pharmaceuticals Limited Approves Dividend for the Financial Year Ended on March 31, 2021	21-10-20	CI
Lincoln Pharmaceuticals : Gets Regulatory Approval to Launch Products in Australia	21-10-08	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Lincoln Pharmaceuticals Limited

Equities

LINCOLN

INE405C01035

Highlights

Filters